About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Drug may Help Prevent Diabetes

by Savitha C Muppala on August 13, 2012 at 11:18 PM
Font : A-A+

 New Drug may Help Prevent Diabetes

Researchers led by scientists at the University of California, San Francisco (UCSF) have uncovered a new key player in amplifying stress in the earliest stages of diabetes: a molecule called thioredoxin-interacting protein (TXNIP).

At its most fundamental level, diabetes is a disease characterized by stress-microscopic stress that causes inflammation and the loss of insulin production in the pancreas, and system-wide stress due to the loss of that blood-sugar-regulating hormone.

Advertisement

The molecule, they've discovered, is central to the inflammatory process that leads to the death of the cells in the human pancreas that produce insulin.

"This molecule does something remarkable -- it takes stress and makes it worse," said the senior author of the study, UCSF's Feroz Papa, MD, PhD, an associate professor of medicine at UCSF and a member of the UCSF Diabetes Center and the California Institute for Quantitative Biosciences (QB3).
Advertisement

The work provides a roadmap for finding new drugs that could target and shut down the action of TXNIP, thus preventing or stalling the inflammatory processes it amplifies.

Researchers in the field believe that this strategy could benefit people in the early days of the disease, when diabetes is first developing or is soon to develop-a time referred to as the "honeymoon" period.

Clinical studies have already shown that dietary changes and other approaches can extend the honeymoon period in some people and prevent diabetes in others. The overarching goal of Papa's research, he said, is to find a way to extend this honeymoon period indefinitely.

What this suggests, said Papa, is that inhibiting TXNIP in people may protect their beta cells, perhaps delaying the onset of diabetes-an idea that that will now have to be developed, translated and tested in clinical trials.

The study was published this week in the journal Cell Metabolism.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Black Water: Benefits and Uses
World Hypertension Day 2022 - Measure Blood Pressure Accurately, Control It, Live Longer!
Drinking This Popular Beverage May Drop Dementia Risk
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetic Retinopathy Drug Toxicity Diabetes Diabetic Diet Clinical Trials - Different Phases of the trial Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise Signature Drug Toxicity Stress Relief Through Alternative Medicine 

Most Popular on Medindia

Vent Forte (Theophylline) Loram (2 mg) (Lorazepam) Iron Intake Calculator Blood Pressure Calculator Turmeric Powder - Health Benefits, Uses & Side Effects Drug Interaction Checker Pregnancy Confirmation Calculator Diaphragmatic Hernia Accident and Trauma Care Selfie Addiction Calculator

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use